International Stem Cell (OTCMKTS:ISCO) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened

Shares of International Stem Cell Corp. (OTCMKTS:ISCO) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.19 and traded as high as $0.4980. International Stem Cell shares last traded at $0.4980, with a volume of 51,459 shares trading hands.

International Stem Cell Price Performance

The stock has a 50 day simple moving average of $0.25 and a 200-day simple moving average of $0.19. The firm has a market cap of $3.99 million, a PE ratio of -6.22 and a beta of -0.03.

International Stem Cell (OTCMKTS:ISCO) last released its earnings results on Thursday, August 13th. The biotechnology company reported ($0.01) EPS for the quarter. The firm had revenue of $2.67 million during the quarter.

International Stem Cell Company Profile

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.